Avoiding antibody aggregation during processing: establishing hold times.
about
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody.Continuous downstream processing for high value biological products: A Review.Downstream Processing Technologies/Capturing and Final Purification : Opportunities for Innovation, Change, and Improvement. A Review of Downstream Processing Developments in Protein Purification.Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumabCharacterization of operating parameters for XMuLV inactivation by low pH treatment.Development of adsorptive hybrid filters to enable two-step purification of biologics.High-throughput analysis of sub-visible mAb aggregate particles using automated fluorescence microscopy imaging.Choosing the right protein A affinity chromatography media can remove aggregates efficiently.Use of polymeric membranes for purification of an E. coli expressed biotherapeutic protein.
P2860
Q30384726-1AE1303C-06B6-4064-8DA1-99633FDA8CE1Q36212815-2F408A76-101F-474A-8460-BD723836F40CQ38543755-5C1BBEB1-0E3A-4D5B-B8CF-3AAECD4842FFQ38631194-3C519EBD-DFEB-43C2-8039-435D2628E687Q38823875-057E5E63-0A27-46B2-964A-E0B008E63114Q40406903-B92F06DB-FBCA-4726-98C0-515765A28217Q40435773-053F3786-346A-46B2-929A-4A2A63F0EA86Q46376020-D160A412-8C64-4596-A668-C6E48BABA692Q51155609-68E314E0-E114-41F2-AC17-7243AC4FEC58Q53182765-1EA8E498-C8EB-4FE9-9464-3DC28162FF9F
P2860
Avoiding antibody aggregation during processing: establishing hold times.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Avoiding antibody aggregation during processing: establishing hold times.
@en
Avoiding antibody aggregation during processing: establishing hold times.
@nl
type
label
Avoiding antibody aggregation during processing: establishing hold times.
@en
Avoiding antibody aggregation during processing: establishing hold times.
@nl
prefLabel
Avoiding antibody aggregation during processing: establishing hold times.
@en
Avoiding antibody aggregation during processing: establishing hold times.
@nl
P2093
P2860
P356
P1476
Avoiding antibody aggregation during processing: establishing hold times
@en
P2093
Anurag Rathore
Nitin Yadav
Tarun Shivach
Varsha Joshi
P2860
P304
P356
10.1002/BIOT.201400052
P50
P577
2014-05-12T00:00:00Z